CopyMark Law Group
4.9/5
Drawing for CONCORDIA RX

USPTO serial 98553736

CONCORDIA RX

Reviewed by CopyMark Law Group

Reg. 8249086Status 700Registered
Filing date
Status date
Registration date
May 12, 2026
Examiner
DIBBLE,JENNA M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CONCORDIA RX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caroline Duncan

Caroline Duncan Baker Botts L.L.P.2001 Ross AvenueSuite 900Dallas, TX 75201-2980

Goods and services

ClassDescriptionStatusFirst use
005a full line of pharmaceuticals for the treatment of depression, malaria, benign prostatic hyperplasia, partial seizures in adults with epilepsy, heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute enterocolitis, and duodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids)ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 12, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 12, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 19, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 10, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 26, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 23, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 23, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 27, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 27, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 18, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 22, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2024DOCKASSIGNED TO EXAMINER—
Nov 18, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 18, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 16, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance